WELL Health Technologies Corp T.WELL

More Analysis

[retiredcf]

Q: To me WELL is hitting on all cylinders but it is unloved within the market. This from it's latest results:

WELL reported record quarterly revenues of $126.5 million in Q1-2022 representing a 395% year-over-year (YoY) increase compared to Q1-2021, catapulting the Company to over $500 million annualized revenue run-rate. Revenues reflected accelerating organic growth to 15% on a YoY basis

Response: EPS of 4c nicely beat estimates. Revenue was $126.5M, ahead of $119M estimates. EBITDA of $23.5M was ~$4M ahead of forecast. WELL raised its guidance and expects to be profitable for the full year. It did a $30M financing which took the shine out of the reaction to the good report. But a major shareholder was the lead order on the financing. We are comfortable with these results and forecast. (5iResearch)

[speedy99]

retiredcf, thank you for this and all previous posts from 5iResearch.  They seem to take a very balanced approach to matters, and I like the format of responding to client's questions.  As a result, I am thinking of signing up for the service myself. I think also that your previous suggestions about content on this board were appropriate and well received here.  I am as guilty